Altimmune's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Altimmune (NASDAQ:ALT) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-0.43. Analysts and investors are looking for an earnings beat and positive guidance for future growth. Despite beating EPS estimates in the past quarters, Altimmune's stock price has shown mixed reactions. Currently, shares are trading at $8.53, reflecting a 99.31% increase over the last 52 weeks. Investors remain optimistic as the earnings date approaches.
March 26, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Altimmune is expected to report an EPS of $-0.43 for the upcoming quarter. Historical data shows mixed stock price reactions to past earnings performances, despite consistent EPS beats. With a significant 99.31% increase in share price over the last year, investor sentiment appears positive ahead of the earnings announcement.
Given Altimmune's history of beating EPS estimates and the significant year-over-year stock price increase, investor optimism is high. However, the mixed reactions to past earnings beats suggest that the actual impact on the stock price could vary. The anticipation of positive future guidance could further bolster investor confidence and potentially lead to a positive short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100